Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSCW) Income from Non-Controlling Interests (2020 - 2025)

Historic Income from Non-Controlling Interests for Ensysce Biosciences (ENSCW) over the last 6 years, with Q2 2025 value amounting to -$166.0.

  • Ensysce Biosciences' Income from Non-Controlling Interests changed N/A to -$166.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$166.0, marking a year-over-year increase of 8402.31%. This contributed to the annual value of -$74.0 for FY2024, which is 9943.94% up from last year.
  • Per Ensysce Biosciences' latest filing, its Income from Non-Controlling Interests stood at -$166.0 for Q2 2025.
  • In the past 5 years, Ensysce Biosciences' Income from Non-Controlling Interests registered a high of $12226.0 during Q4 2022, and its lowest value of -$35948.0 during Q3 2021.
  • Over the past 5 years, Ensysce Biosciences' median Income from Non-Controlling Interests value was -$2588.0 (recorded in 2023), while the average stood at -$7930.3.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first surged by 581308.41% in 2022, then tumbled by 226538.46% in 2023.
  • Ensysce Biosciences' Income from Non-Controlling Interests (Quarter) stood at -$214.0 in 2021, then skyrocketed by 5813.08% to $12226.0 in 2022, then crashed by 107.89% to -$965.0 in 2023, then skyrocketed by 92.33% to -$74.0 in 2024, then plummeted by 124.32% to -$166.0 in 2025.
  • Its Income from Non-Controlling Interests stands at -$166.0 for Q2 2025, versus -$74.0 for Q1 2024 and -$965.0 for Q4 2023.